Account Risk Watch 2026-10-05: Acme Corp High 76, Globex Med 58, both entities unconfirmed
Interpretation: The Acme renewal date (2025-03-15) is about 19 months before this run (2026-10-05). I treat it as given and flag it as past or stale, so the lens is renewal (lapsed or unconfirmed status). Globex has no renewal date, only an open deal, so I scored it on the deal lens even though the stated focus is renewal. Window: 2026-09-28 to 2026-10-05.
Week summary: Scores rest on your internal data only. No public signal could be tied to either account, because neither row gave a domain or HQ and both names are shared by many unrelated companies.
| Account/Deal | Risk score | Trend vs last run | Top drivers (internal data) | Public signals (with dated links) | Key date | Recommended next action and owner |
|---|---|---|---|---|---|---|
| Acme Corp (entity unconfirmed) | High 76 | first run | "logins down 40% QoQ"; "6 P1 tickets in 30 days"; renewal 2025-03-15 (past) | Entity unconfirmed, public scoring skipped. Unattributed hits only (see near misses). | 2025-03-15 (as supplied; past) | AM: confirm today whether the 2025-03-15 renewal closed or lapsed, then get an exec sponsor call with J. Lee (VP Ops) on the P1 tickets. |
| Globex (entity unconfirmed) | Med 58 | first run | "no reply since 2 weeks"; "single-threaded"; open deal $120k, stage proposal | Entity unconfirmed, public scoring skipped. | not found | Seller: send a short re-engagement note to R. Patel and ask for a second stakeholder or sponsor introduction. |
Evidence notes for non-clean rows
- Acme Corp (High 76): The score comes from internal data only: the 40% login drop and six P1 tickets in 30 days are both on your highest-weighted signals list (usage drop) or imply service pain. The stale renewal date is a data conflict. If the contract renewed in 2025, the next renewal date is missing; if it lapsed, this is a win-back. Judgment, not fact: I rate it High even without public signals. Champion J. Lee's status was not checked (no employer domain to match).
- Globex (Med 58): Two weeks of silence and single-threading are classic slippage markers. With no deal date, close timing cannot be assessed. Judgment: Med rather than High, because there is no usage, ticket or public evidence of loss.
- Entity ambiguity (both): Search-result titles (not opened) for Acme pointed to a supermarket chain's WARN notice, a sample renewal-risk PDF and a company-profile page; titles for Globex pointed mostly to a gold-mining company (Kalkine, 2026-09-30). None matches a customer with a VP Ops champion or a $120k software deal, so I did not attribute any of them.
Do next
- Acme: verify contract status for the 2025-03-15 renewal in CRM today (AM).
- Acme: open a P1 root-cause review and share it with J. Lee (CS lead).
- Globex: re-engage R. Patel within 48 hours and ask for a second contact (Seller).
- Both: add official domain and HQ to each row so the next edition can run public checks (AM/Seller).
Near misses / open items
- Unattributed search hits for "Acme" (a grocery chain's WARN notice listing, 2026-08-15, outside the window and a different company) are not counted.
- No champion role changes, competitor mentions, or budget-freeze evidence were found for J. Lee or R. Patel; not checkable without employer identity.
Data gaps
No official domain, HQ, industry or employer for either account; no prior edition; no Acme renewal outcome; no Globex deal close date, deal history, or reply log; no usage data for Globex.
Coverage
Web search only for entity resolution. Newsroom, LinkedIn, layoff trackers, funding, filings, job boards and review sites: unchecked for both accounts (entity unconfirmed). Scores are recommendations for you to confirm, not financial or legal advice.